Specialized Modalities

Modality Leadership

Established experience in Cell & Gene (25+ years), mRNA (5+ years), and Microbial (30+ years)

450+ Process Development Projects:

Proven track record transforming cutting-edge science into scalable, advanced manufacturing – backed by modern, purpose-built facilities

16 Pre-Licensing Inspections (PLIs) Passed:

Regulatory confidence at every stage, with deep expertise in bringing products to market

Specialized Modalities

Contract Development Manufacturing Services

Cell & Gene

Established expertise accelerating your path to IND and beyond to commercialize and deliver cell and gene therapies

Learn more

mRNA/LNP

Benefit from our end-to-end services for manufacturing and development of mRNA/LNP products

Learn more

Microbial

Scale and futureproof your next-gen biologic with Lonza’s advanced microbial fermentation services

Learn more

Products and Technologies

Bioscience Products

Our products and services range from cell culture and discovery technologies for research to quality control tests and software for biomanufacturing

Learn More

Related Insights

Visit Knowledge Center

Blog

Inhalable mRNA lipid nanoparticle powders via spray drying: is it possible?

Dry powder inhaled formulations of small molecule drugs are a mainstay of treatment for respiratory...

Webinar (on-demand)

In Vivo CAR-T And Gene Editing: The Manufacturing Reality Behind The Promise

In vivo CAR-T is moving fast, and so are the manufacturing challenges behind it. LNPs and viral...

Poster

Advancing Lentiviral Genome Integrity and Titer Analysis Via Two Dimensional Reverse...

Lentiviral vectors (LVVs) are powerful and versatile gene‑transfer tools widely used in both ex vivo...

Webinar (on-demand)

What It Takes to Scale: Translating Microbial Early Decisions into Commercial Readiness

Scaling up microbial manufacturing remains one of the most complex and often underestimated...

Webinar (on-demand)

In Vivo CAR-T Manufacturing: Cracking the Code of Complex Analytics and Processes

Mastering chemistry, manufacturing, and control complexities for in vivo CAR-T therapies, including...

White paper

Early preclinical development of RNA/LNP projects: Transitioning successfully to cGMP manufacturing

Download our white paper on exploring the development steps that lead to an mRNA construct optimized...

Podcast

A View On Spray-Drying mRNA-based Products

In this episode, we speak with Carsten Rudolph, CEO and co-founder of Ethris, about a novel...

Podcast

A View On Microbial Manufacturing (S04 E06)

In this episode, we hear from Karlheinz Flicker and Joan Cortada, two experts from Lonza's microbial...

Webinar (on-demand)

Fixing the Fixed: Unlocking Efficiency in Large-Scale Microbial Manufacturing

It's often assumed that bioprocesses become fixed and unchanging as they move into commercial...

Visit Knowledge Center